| Literature DB >> 26581058 |
Misha L Baker1, Daniella Figueroa-Downing1, Ellen Dias De Oliveira Chiang2, Luisa Villa3, Maria Luiza Baggio3, José Eluf-Neto4, Robert A Bednarczyk1, Dabney P Evans1.
Abstract
In 2014, Brazil introduced an HPV immunization program for girls 9-13 years of age as part of the Unified Health System's (SUS) National Immunization Program. The first doses were administered in March 2014; the second ones, in September 2014. In less than 3 months more than 3 million girls received the first dose of quadrivalent HPV vaccine, surpassing the target rate of 80%. This paper examines three elements that may influence the program's long-term success in Brazil: sustaining effective outreach, managing a large technology-transfer collaboration, and developing an electronic immunization registry, with a focus on the State of São Paulo. If these three factors are managed, the Government of Brazil is primed to serve as a model of success for other countries interested in implementing a national HPV vaccination program to decrease HPV-related morbidity and mortality.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26581058
Source DB: PubMed Journal: Rev Panam Salud Publica ISSN: 1020-4989